2010200920082007200620052004200220012000

We comply with the HONcode standard for trustworthy health information:
verify here.

Free Mesothelioma Information Packet

Enter your information to receive a comprehensive mesothelioma packet free of charge at your doorstep within 24 hours.

Mesothelioma News

2002

Eli Lilly boosted by mesothelioma treatment drug Alimta®

New Haven, Connecticut - May 21, 2002

Alimta®, a new type of cancer treatment being developed by Eli Lilly, is the first treatment to significantly increase the length of survival and ameliorate the symptoms of the disease.

Last modified: March 15 2010

1-800-336-0086

If you have any questions regarding your legal rights, please contact us.
New York Office 360 Lexington Ave., 20th Floor New York, New York, 10017 (P): 212-986-2233 (F): 212-986-2255
New Haven Office One Century Tower, 265 Church Street New Haven, CT 06508-1866 (P): 203-777-7799 (F): 203-785-1671

Thank you for visiting this website which is created for the benefit of the general public. This website and its content are produced and sponsored by the law firm of James F. Early, LLC (James F. Early, Esq.). This website is devoted to the needs of people diagnosed with mesothelioma; nonetheless it may be considered attorney advertising. The content contained herein was not prepared by medical professionals and it is not intended, nor should it be considered, as a substitute for medical advice. The information provided on this website is intended as educational material, designed solely to support, and not replace, the relationship that exists between a patient/site visitor and his/her healthcare professional. Additionally, neither visiting this website nor viewing its content is intended, and shall not be considered, to create an attorney-client relationship. An attorney-client relationship can only be created by mutual agreement and consent of the prospective client and the attorney. Neither the transmission nor receipt of this website material will create an attorney-client relationship between sender and receiver. The material contained herein is general in nature and may not apply to your particular factual or legal circumstances. Online readers should not act on this information without seeking professional counsel and advice. Please read our disclaimer for more information.